15:51 Dec 27
Concord Biotech Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Biotechnology
Concord Biotech Ltd.
75/100 High Financial Strength
Quality12/100 Expensive Valuation
Valuation62/100 Technically Moderately Bullish
TechnicalSWOT
Strength
12
Weakness
1
Opportunity
1
Threat
1
22.65K
Market Cap (Cr)
69.08
PE Ratio
14.24
Price to Book Ratio
57.27
RSI
30.29 %
Net Profit Margin
SWOT
Download Our App On:
